(3S,4S,5R,6R)-6-(Hydroxymethyl)-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,3,5-triol

Term ID

CHEBI:153184

Synonyms

alpha-D-manno-hexopyranosyl-(1->6)-alpha-D-manno-hexopyranosyl-(1->3)-D-manno-hexopyranose
Man(a1-6)Man(a1-3)Man
WURCS=2.0/2,3,2/[a1122h-1x_1-5][a1122h-1a_1-5]/1-2-2/a3-b1_b6-c1

Definition

References

GlyGen:G71610GM
GlyTouCan:G71610GM

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (3S,4S,5R,6R)-6-(Hydroxymethyl)-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,3,5-triol

Phenotype where environments contain (3S,4S,5R,6R)-6-(Hydroxymethyl)-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,3,5-triol

Phenotype modified by environments containing (3S,4S,5R,6R)-6-(Hydroxymethyl)-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,3,5-triol

Phenotype affecting (3S,4S,5R,6R)-6-(Hydroxymethyl)-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyoxane-2,3,5-triol

Human Disease Model